<DOC>
	<DOCNO>NCT00081003</DOCNO>
	<brief_summary>RATIONALE : Screening test , nipple aspiration , ductal lavage , breast duct endoscopy , may help doctor detect cancer cell early plan effective treatment breast cancer . PURPOSE : This clinical trial study well nipple aspiration , ductal lavage , breast duct endoscopy work detect cancer cell healthy woman moderate-to-high risk develop breast cancer .</brief_summary>
	<brief_title>Nipple Aspiration , Ductal Lavage , Duct Endoscopy Screening Women Moderate-to-High Risk Developing Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine incidence mild severe cellular atypia nipple aspirate fluid healthy woman moderate high risk develop breast cancer , define family history prior atypical biopsy . Secondary - Correlate cellular atypia breast cancer , biochemical tumor marker , growth factor , genetic protein marker participant . - Determine cancer risk incidence utilize method screen participant . - Observe natural history atypia participant total 10 year . - Determine whether technique may serve supplementary tool future screen participant . OUTLINE : Participants 50 year age undergo nipple aspiration every twelve month 3 year . Participants 50 year age undergo nipple aspiration every 18 month 4.5 year . Participants significant cellular atypia nipple aspirate fluid undergo ductal lavage endoscopy . Participants follow annually total 10 year . PROJECTED ACCRUAL : A total 1,000 participant accrue study within approximately 4 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Significant family history prior atypical biopsy indicative moderate high risk develop breast cancer No concurrent inflammatory breast cancer Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age 18 64 Sex Female Menopausal Status Premenopausal postmenopausal Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No prior allergy EMLA cream lidocaine No severe illness would preclude study participation No mental illness handicap would preclude study compliance No concurrent active infection inflammation breast study Not unconscious Not pregnant No nursing within past 12 month PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery No prior subareolar surgery ( e.g. , microdochectomy major duct excision ) may disrupt ductal system within 2 cm nipple No prior breast implantation propose lavage side</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>breast cancer</keyword>
</DOC>